CRYOPORT ($NASDAQ:CYRX) reported total revenue of USD 57.0 million for the second quarter of the fiscal year 2023 which ended on June 30 2023, representing a decrease of 11.1% from the same quarter in the previous year. The net income for the quarter was USD -18.4 million, compared to a net loss of USD 9.2 million during the corresponding period of the preceding fiscal year.
GoodWhale has conducted an analysis of CRYOPORT‘s wellbeing, using the Star Chart. According to this chart, CRYOPORT has an intermediate health score of 4/10 with regard to its cashflows and debt. While this indicates that there may be some concern about their ability to pay off debt and fund future operations, it is still classified as ‘cheetah’, a type of company which has achieved high revenue or earnings growth but is considered less stable due to lower profitability. CRYOPORT is strong in terms of asset and growth, but weak in dividend and profitability. Investors who are willing to take on the risky nature of such a business may be interested in investing in CRYOPORT. This could include venture capitalists, hedge funds, and angel investors who are looking for a high-risk, high-reward type of investment. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Cryoport. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cryoport. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cryoport. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Cryoport are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
In the logistics and transportation industry, there is intense competition among companies to provide the most efficient and cost-effective services. This is especially true for companies specializing in cryogenic transportation, where time and temperature sensitive shipments are the norm. In this arena, CryoPort Inc. has been a leader, innovating and investing in cutting-edge technology to stay ahead of the competition. Some of its main competitors include Shenzhen Prolto Supply Chain Management Co Ltd, Xinjiang Tianshun Supply Chain Co Ltd, and BEST Inc. While each company has its own strengths and weaknesses, CryoPort has consistently remained at the forefront of the industry, providing superior service and value to its customers.
– Shenzhen Prolto Supply Chain Management Co Ltd ($SZSE:002769)
Shenzhen Prolto Supply Chain Management Co Ltd has a market cap of 3.23B as of 2022, and a Return on Equity of 2.47%. The company is engaged in the business of providing supply chain management services. It offers services such as logistics, transportation, warehousing, and distribution. The company has a network of over 1,000 warehouses in China.
– Xinjiang Tianshun Supply Chain Co Ltd ($SZSE:002800)
Xinjiang Tianshun Supply Chain Co Ltd is a Chinese company that operates in the logistics and supply chain management industry. The company has a market capitalization of 2.2 billion US dollars as of 2022 and a return on equity of 6.85 percent. Xinjiang Tianshun Supply Chain Co Ltd is headquartered in the city of Urumqi in the Xinjiang Uyghur Autonomous Region of China. The company was founded in the year 2006.
BEST Inc. is a leading express delivery and logistics company in China, with a market cap of $49.1 million as of 2022. The company has a return on equity of -60.92%. BEST Inc. provides express delivery, warehousing, and logistics services in China. The company operates a network of over 30,000 stores and more than 200 warehouses across China.
Investors looking at CRYOPORT as an investment opportunity should note that the company reported a total revenue of USD 57.0 million for Q2 of FY2023, which is an 11.1% decrease from the same quarter in the previous year. This might be indicative of a negative trend in the company’s performance, and should be taken into account when making an investment decision.